Alector (ALEC) Cash & Equivalents (2018 - 2026)
Alector's (ALEC) quarterly Cash & Equivalents came in at $59.9 million in Q2 2026, up 33.83% year-over-year from $44.8 million in Q2 2025, and down 22.15% quarter-over-quarter from $77.0 million in Q1 2026.
Analysis
Alector (ALEC) Cash & Equivalents (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Cash & Equivalents for 9 consecutive years, with $59.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 33.83% year-over-year to $59.9 million in Q2 2026; TTM through Jun 2026 was $59.9 million, a 33.83% increase from a year earlier, with the FY2025 full-year figure at $65.8 million, up 99.27% from the prior year.
- Cash & Equivalents was $59.9 million for Q2 2026 at Alector, down from $77.0 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $454.6 million in Q1 2022 and troughed at $33.0 million in Q4 2024.
- A 5-year average of $112.3 million and a median of $75.5 million in 2023 frame the typical range for Cash & Equivalents.
- The widest YoY moves for Cash & Equivalents: up 310.67% in 2022, down 64.33% in 2022.
- Over 5 years, Cash & Equivalents stood at $154.3 million in 2022, then tumbled by 51.69% to $74.6 million in 2023, then slumped by 55.71% to $33.0 million in 2024, then surged by 99.27% to $65.8 million in 2025, then dropped by 8.95% to $59.9 million in 2026.
- The last three Cash & Equivalents figures came in at $59.9 million (Q2 2026), $77.0 million (Q1 2026), and $65.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 13.99 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 3.18 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 6.14 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 2.46 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 3.58 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 1.72 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.71 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 1.29 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 544.80 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 59.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.92 Mn |
| Mar 31, 2026 | 76.96 Mn |
| Dec 31, 2025 | 65.80 Mn |
| Sep 30, 2025 | 76.50 Mn |
| Jun 30, 2025 | 44.77 Mn |
| Mar 31, 2025 | 37.97 Mn |
| Dec 31, 2024 | 33.02 Mn |
| Sep 30, 2024 | 37.16 Mn |
| Jun 30, 2024 | 47.55 Mn |
| Mar 31, 2024 | 72.55 Mn |
| Dec 31, 2023 | 74.56 Mn |
| Sep 30, 2023 | 101.96 Mn |
| Jun 30, 2023 | 131.54 Mn |
| Mar 31, 2023 | 195.56 Mn |
| Dec 31, 2022 | 154.32 Mn |
| Sep 30, 2022 | 184.23 Mn |
| Jun 30, 2022 | 172.27 Mn |
| Mar 31, 2022 | 454.62 Mn |
| Dec 31, 2021 | 329.15 Mn |
| Sep 30, 2021 | 516.53 Mn |